Brain Ultrasound in the Weaning of External Ventricular Leads

University Hospital, Toulouse30 enrolled

Overview

External Ventricular Deviation (EDV) is a medical device that provides transient and controlled external drainage of cerebrospinal fluid (CSF). This device can also monitor intracranial pressure (ICP). SEV is an emergency measure indicated for acute hydrocephalus and / or intracranial hypertension (HTIC). Weaning from a DVE should be considered as soon as possible from the moment the patient's clinical condition allows it. There is no consensus on how to wean SEVs. The main objective of this study is to evaluate inter and intraobserver reproducibility of the measurement of the 3rd ventricle size by ultrasound in patients receiving a DVE withdrawal test.

Ultrasound assessment of the ventricular system, including the size of the 3rd ventricle, can be used in severe traumatic brain injury. Ultrasound measurement of the size of the 3rd ventricle is used as a marker to monitor cerebral atrophy in neurodegenerative diseases such as multiple sclerosis (MS). There is good correlation between brain ultrasound and MRI and CT brain imaging to assess the size of the 3rd ventricle. Ultrasound measurement of the size of the 3rd ventricle has never been evaluated in weaning external ventricular leads. Measuring the size of the 3rd ventricle by ultrasound could be an interesting monitoring technique during a SEV withdrawal trial to predict success or failure. Weaning is usually based on a clamp test with more or less paraclinical clinical monitoring. The recurrence of hydrocephalus and / or HTIC defines a withdrawal failure of the drainage device. The size of the 3rd ventricle evaluated by cerebral CT in a clamp test is found as a predictor of weaning failure of a DVE.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hydrocephalus Intracranial Hypertension

Interventions

Measuring the size of the 3rd ventricle by ultrasoundOTHER

The surveillance of the clamping test is essentially clinical. No cerebral imaging is performed systematically in our service protocol.The study consisted of including ultrasound measurements during the usual weaning protocol of the service.All patients receiving a SEV withdrawal test will be included. Inclusion begins when the clinician in charge of the patient initiates the withdrawal test. The measurements will be performed blindly by a trained physician who does not participate in the patient's care. Four measurements will be made, with recording of ultrasound loops

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient benefiting from a DVE, whatever the indication * Hospitalized in the neurosurgical resuscitation and neurosurgical intensive care units of Toulouse University Hospital * First DVE withdrawal test initiated by the doctor in charge of the patient * Major patient * Affiliated person or beneficiary of a social security scheme. * Expression of non-opposition by the participant or his / her confidant and the investigator (at the latest on the day of inclusion and before any examination required by the research). Exclusion Criteria: * Absence of cerebral acoustic window * Patient with a ventriculoperitoneal (DVP) diversion before the DVE. * Antecedent surgery in the cerebral ventricular system. * Pregnant and lactating woman * Person under safeguard of justice * Nosocomial neuro-meningeal infection on untreated or treatment-emergent DVE

Outcomes

Primary Outcomes

Inter individual reproducibility of ultrasound measurement of the size of the 3rd ventricle

Inter individual reproducibility of ultrasound measurement of the size of the 3rd ventricle at different study times The inter-individual reproducibility will be evaluated at each time by the analysis of a loop by 3 independent and blind operators. The analysis of all ultrasound loop recordings will be performed at the end of the participation of the last included patient. The recordings of the ultrasound loops will be coded and presented in a random and different order to each operator.

Time frame: 3 weeks

Intra individual reproducibility of ultrasound measurement of the size of the 3rd ventricle

Intra individual reproducibility of ultrasound measurement of the size of the 3rd ventricle at different study times The intra-individual reproducibility will be evaluated at each time by the acquisition of 3 ultrasound loops analyzed by the same operator. The analysis of all ultrasound loop recordings will be performed at the end of the participation of the last included patient. The recordings of the ultrasound loops will be coded and presented in a random and different order to each operator.

Time frame: 3 weeks

Secondary Outcomes

Measurement of the evolution of the size of the 3rd ventricle (intra individual)

Intra individual reproducibility of the ultrasound measurement of the evolution of the size of the 3rd ventricle

Time frame: 3 weeks

Measurement of the evolution of the size of the 3rd ventricle (inter individual)

Inter individual reproducibility of the ultrasound measurement of the evolution of the size of the 3rd ventricle

Time frame: 3 weeks

Successful completion of the DVE withdrawal test

Successful completion of the DVE withdrawal test, defined by the absence of the need to decline or rest a DVE at 3 weeks.

Time frame: 3 weeks

Failure of the weaning test

Failure of the weaning test defined by the need to decline or rest a DVE at 3 weeks.

Time frame: 3 weeks

Brain Ultrasound in the Weaning of External Ventricular Leads

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes

Central Contacts